LPT 200 mg Pill: white, capsule/oblong
The pill with imprint LPT 200 mg (White, Capsule/Oblong, 0mm) has been identified as Topiramate Extended-Release 200 mg and is used for Lennox-Gastaut Syndrome, Migraine Prevention, Epilepsy, Seizure Prevention, and Seizures. It belongs to the drug class carbonic anhydrase inhibitor anticonvulsants and is not a controlled substance.
Images for LPT 200 mg
Topiramate Extended-Release
- Imprint
- LPT 200 mg
- Strength
- 200 mg
- Color
- White (opaque white)
- Shape
- Capsule/Oblong (capsule)
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Vitruvias Therapeutics, Inc.
- National Drug Code (NDC)
- 69680-0181
Related images for "LPT 200 mg"
More about topiramate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,343)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
Patient resources
Other brands
Topamax, Trokendi XR, Eprontia, Qudexy XR, Topiragen
Professional resources
- Topiramate monograph
- Topiramate (FDA)
- Topiramate Capsules (FDA)
- Topiramate ER Capsules (FDA)
- Topiramate Oral Solution (FDA)
- Topiramate Tablets (FDA)
Other brands
Topamax, Trokendi XR, Eprontia, Qudexy XR
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.